thyroid hormone deficiency
Endocrinology · 2015–2016
2decisions
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| thyroxine sodium Management of demonstrated thyroid hormone deficiency and suppression of thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid, in the… | Mar 2016 | Not recommended | input received Hospital Network |
| thyroxine sodium Management of demonstrated thyroid hormone deficiency and suppression of thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid. | Nov 2015 | Recommended | unclear |
Who spoke
Hospital Network
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.